Oleuropein.

Olive leaf extract is standardised on oleuropein, so the two are the same molecule presented at different purities. Listing both in one formula adds to the same oleuropein intake rather than combining separate actives.

Oleuropein is hydrolysed in the gut and liver to hydroxytyrosol, which is the main phenol of olive fruit extract. The two overlap on the same downstream metabolite pool.

Ascorbate reduces the oxidised catechol form of oleuropein back to its active state after it quenches a radical. That is the standard recycling relationship between ascorbate and dietary polyphenols.

Alpha-tocopherol protects the lipid interior of membranes and is consumed as it does so. Olive phenols can regenerate the tocopheroxyl radical at the membrane surface, which spares tocopherol.

The catechol ring of oleuropein and hydroxytyrosol binds ferric iron strongly in the gut lumen. Taken alongside a non-heme iron dose it lowers how much of that iron is absorbed.

Catechol phenols bind copper as well as iron, holding it in a complex the intestine takes up less readily. The same binding is part of how these phenols hold down metal-driven radical formation.

NAC supplies cysteine, the limiting amino acid for glutathione synthesis, while olive phenols push Nrf2-driven expression of the enzymes that build and use it. One provides substrate and the other raises enzyme capacity.

Both phenols are cleared largely by sulfation, and taken together they compete for the same sulfotransferase capacity. That competition raises circulating exposure to each.

Oleuropein's phenols and quercetin are conjugated by the same intestinal sulfotransferases and UGT enzymes. Taken together each occupies part of that capacity and both can reach higher circulating levels.

Oleuropein is an ester of hydroxytyrosol with elenolic acid glucoside. Esterases and beta-glucosidases in the gut and in olive tissue cleave it, releasing hydroxytyrosol as the main absorbed phenol. So a large part of what oleuropein does in the body is done by hydroxytyrosol after conversion. Supplying both means supplying a precursor and its product at once.

Olive polyphenols are absorbed better from a lipid matrix than from a dry powder, and virgin olive oil carries a related phenolic fraction of its own. Co-dosing is both a delivery choice and a source overlap. The oil contributes its own hydroxytyrosol and oleocanthal, so a combined product should not double count. The pairing is formulation convention with a chemical basis.

Most ingested oleuropein reaches the colon intact, where bacterial beta-glucosidases and esterases release hydroxytyrosol and further metabolites. The gut community therefore determines a large share of what is absorbed. Whether adding a specific live culture increases that conversion in a person has not been measured. The conversion step itself is settled microbiology.

Lactobacillus plantarum strains carry the glycosidase and esterase activities that debitter olives during fermentation, which is the same chemistry that converts oleuropein into hydroxytyrosol. That is why the species turns up in olive processing. Whether a capsule dose reproduces the effect in the colon is untested. The enzymology is documented, the human combination is not.

The catechol group of oleuropein and its hydroxytyrosol metabolite participates in the same redox network glutathione supports, and animal work reports higher tissue glutathione and glutathione peroxidase activity with olive polyphenol feeding. Those are enzyme and marker readings rather than clinical outcomes. Co-supplying the two has not been measured in people. The chemistry is settled, the combined effect is not.

Lipoic acid regenerates other antioxidants in the cellular redox cycle, and phenolic antioxidants such as oleuropein feed into the same network. The interaction is chemical rather than clinical. No combination data exists for the pair. It sits here as formulation logic at low confidence.

Coenzyme Q10 in its reduced form limits lipid peroxidation within membranes, while phenolics such as oleuropein act more at the aqueous interface. Two different positions in the same process is the reason the pair appears in blends. No combination measurement exists. Lipid oxidation markers are laboratory measures.

Long-chain polyunsaturated fatty acids oxidise readily, and oleuropein supplementation in animals altered plasma fatty acid profiles alongside antioxidant defence measures. Adding a phenolic antioxidant to a polyunsaturated oil is a standard way to limit that oxidation in the product itself. The animal evidence speaks to plasma markers, not to a clinical outcome, and does not transfer directly to people.

Catechol-containing polyphenols bind divalent metals, and the same chemistry that lets oleuropein chelate iron and copper applies to zinc. Taken in the same capsule or the same meal, the two can form complexes that reduce free mineral available for uptake. The magnitude has not been quantified for oleuropein specifically. Separating the doses removes the question.

Olive polyphenols have been reported to affect bone turnover markers in animal models, which is why oleuropein appears in bone-support blends alongside calcium. Catechols also bind divalent cations, so the two interact chemically in the same dose. The animal readouts are markers, and none of this has been shown in people. Both directions are worth knowing before combining them.

Absorbed olive phenolics are rapidly glucuronidated and sulfated, and piperine inhibits some of the enzymes doing that work. In principle that raises circulating free phenol. It has been demonstrated for curcumin, not for oleuropein, so the transfer is an assumption. Confidence stays low for that reason.

Phospholipid complexes are a common way to carry poorly absorbed plant phenolics across the intestinal wall, and olive polyphenol phytosome preparations use exactly this approach. The lecithin contributes delivery, not activity. Whether a given complex actually raises absorption is a product-specific measurement. The practice itself is well established.

Olive polyphenol preparations have been studied for effects on metabolic markers, and berberine is a common component of glucose-support formulas working through different chemistry. Stacking them puts two pushes on the same marker panel. There is no combination measurement. Markers are not clinical outcomes.

Catechins and secoiridoid phenols are handled by the same glucuronidation and sulfation enzymes and by overlapping efflux transporters, so a large dose of one can occupy the capacity the other needs. Both also bind dietary iron. The interaction cuts both ways depending on dose and timing. Nothing has quantified it for this specific pair.

Because most oleuropein reaches the colon intact, the composition and activity of the resident microbiota shapes how much hydroxytyrosol is released. Fermentable fibre changes that community. Whether it changes phenolic conversion in a useful direction has not been measured. The row records a plausible interaction at its true low confidence.